Back to results
TerminatedPhase 3

Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

NCT00343980

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

St Leonards, New South Wales, Australia

+25 additional locations

View on ClinicalTrials.gov
Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes — TrialFind